Ausgabe 1/2015
Inhalt (26 Artikel)
Current status of intratumoral therapy for glioblastoma
Ankit I. Mehta, Andreas Linninger, Maciej S. Lesniak, Herbert H. Engelhard
A systematic review of cognitive performance in patients with childhood craniopharyngioma
Jale Özyurt, Hermann L. Müller, Christiane M. Thiel
A novel nanoparticle containing neuritin peptide with grp170 induces a CTL response to inhibit tumor growth
Bangqing Yuan, Hanchao Shen, Tonggang Su, Li Lin, Ting Chen, Zhao Yang
Detection of proneural/mesenchymal marker expression in glioblastoma: temporospatial dynamics and association with chromatin-modifying gene expression
Hideki Murata, Koji Yoshimoto, Ryusuke Hatae, Yojiro Akagi, Masahiro Mizoguchi, Nobuhiro Hata, Daisuke Kuga, Akira Nakamizo, Toshiyuki Amano, Tetsuro Sayama, Koji Iihara
miR-429 inhibits glioma invasion through BMK1 suppression
Weiyi Chen, Baogang Zhang, Wenjun Guo, Linlin Gao, Lihong Shi, Hongli Li, Shijun Lu, Yuqing Liu, Xiaolong Li
Reactive oxygen species production has a critical role in hypoxia-induced Stat3 activation and angiogenesis in human glioblastoma
Mi Ok Yu, Kyung-Jae Park, Dong-Hyuk Park, Yong-Gu Chung, Sung-Gil Chi, Shin-Hyuk Kang
Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma
Smita K. Nair, Timothy Driscoll, David Boczkowski, Robert Schmittling, Renee Reynolds, Laura A. Johnson, Gerald Grant, Herbert Fuchs, Darell D. Bigner, John H. Sampson, Sridharan Gururangan, Duane A. Mitchell
CCND2, CTNNB1, DDX3X, GLI2, SMARCA4, MYC, MYCN, PTCH1, TP53, and MLL2 gene variants and risk of childhood medulloblastoma
Anna M. Dahlin, Mads V. Hollegaard, Carl Wibom, Ulrika Andersson, David M. Hougaard, Isabelle Deltour, Ulf Hjalmars, Beatrice Melin
Specific inhibition of mTOR pathway induces anti-proliferative effect and decreases the hormone secretion in cultured pituitary adenoma cells
Rong Xie, Wen-Qiang He, Ming Shen, Xue-Fei Shou, Yong-Fei Wang, Wei-Min Bao, Yao Zhao
Investigating a signature of temozolomide resistance in GBM cell lines using metabolomics
Patrick-Denis St-Coeur, Julie J. Poitras, Miroslava Cuperlovic-Culf, Mohamed Touaibia, Pier Jr Morin
High levels of polo-like kinase 1 and phosphorylated translationally controlled tumor protein indicate poor prognosis in neuroblastomas
Pramila Ramani, Rachel Nash, Emile Sowa-Avugrah, Chris Rogers
Hugl-1 inhibits glioma cell growth in intracranial model
Xuejiao Liu, Dong Lu, Peng Ma, Huaqiang Liu, Yuewen Cao, Ben Sang, Xianlong Zhu, Qiong Shi, Jinxia Hu, Rutong Yu, Xiuping Zhou
Phase I study of iniparib concurrent with monthly or continuous temozolomide dosing schedules in patients with newly diagnosed malignant gliomas
Jaishri O. Blakeley, Stuart A. Grossman, Tom Mikkelsen, Myrna R. Rosenfeld, David Peereboom, L. Burt Nabors, Andrew S. Chi, Gary Emmons, Ignacio Garcia Ribas, Jeffrey G. Supko, Serena Desideri, Xiaobu Ye
Methotrexate administration directly into the fourth ventricle in children with malignant fourth ventricular brain tumors: a pilot clinical trial
David I. Sandberg, Michael Rytting, Wafik Zaky, Marcia Kerr, Leena Ketonen, Uma Kundu, Bartlett D. Moore, Grace Yang, Ping Hou, Clark Sitton, Laurence J. Cooper, Vidya Gopalakrishnan, Dean A. Lee, Peter F. Thall, Soumen Khatua
Ischemic stroke in patients with gliomas at The University of Texas-M.D. Anderson Cancer Center
Carlos Kamiya-Matsuoka, David Cachia, Shlomit Yust-Katz, Yvo A. Rodriguez, Pedro Garciarena, Elsa M. Rodarte, Ivo W. Tremont-Lukats
Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases
Zachary A. Kohutek, Yoshiya Yamada, Timothy A. Chan, Cameron W. Brennan, Viviane Tabar, Philip H. Gutin, T. Jonathan Yang, Marc K. Rosenblum, Åse Ballangrud, Robert J. Young, Zhigang Zhang, Kathryn Beal
Changes in functional MRI signals after 3D based radiotherapy of glioblastoma multiforme
Árpád Kovács, Miklós Emri, Gábor Opposits, Tamás Pisák, Csaba Vandulek, Csaba Glavák, Zoltán Szalai, Gergely Biró, Gábor Bajzik, Imre Repa
The use of 18F-FDG PET to differentiate progressive disease from treatment induced necrosis in high grade glioma
J. W. Dankbaar, T. J. Snijders, P. A. Robe, T. Seute, W. Eppinga, J. Hendrikse, B. De Keizer
Delayed leukoencephalopathy of non-small cell lung cancer patients with brain metastases underwent whole brain radiation therapy
Xiaoling Zhong, Biao Huang, Jieying Feng, Wanqun Yang, Hongjun Liu
Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma
Alissa A. Thomas, Julio Arevalo-Perez, Thomas Kaley, John Lyo, Kyung K. Peck, Weiji Shi, Zhigang Zhang, Robert J. Young
A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas
Yazmín Odia, Teri N. Kreisl, Dawit Aregawi, Ellen K. Innis, Howard A. Fine
Incidence and spectrum of paraneoplastic neurological syndromes: single center study
Meena A. Kanikannan, Y. Sirisha, Megha S. Uppin, Sheik A. Jabeen, Rukmini M. Kandadai, Challa Sundaram, Digumarti Raghunadharao, Rupam Borgohain
A multicenter study of anaplastic oligodendroglioma: the Korean Radiation Oncology Group Study 13–12
Hyun-Cheol Kang, Tosol Yu, Do Hoon Lim, Il Han Kim, Woong-Ki Chung, Chang-Ok Suh, Byung Ock Choi, Kwan Ho Cho, Jae Ho Cho, Jin Hee Kim, Do-Hyun Nam, Chul-Kee Park, Yong-Kil Hong, In Ah Kim
Bipolar radiofrequency ablation for metastatic spinal tumors: an evolving paradigm in palliative care
Giovanni Grasso
Prevalence of hepatitis B virus in primary central nervous system lymphoma
G. Faivre, V. Thibault, M. L. Tanguy, V. Leblond, S. Choquet, C. Soussain, A. Gonzalez-Aguilar, M. Sierra del Rio, C. Houillier, K. Hoang-Xuan, A. Idbaih
Erratum to: Survival prediction in high-grade gliomas using CT perfusion imaging
Timothy Pok Chi Yeung, Yong Wang, Wenqing He, Benedetta Urbini, Roberta Gafà, Linda Ulazzi, Slav Yartsev, Glenn Bauman, Ting-Yim Lee, Enrico Fainardi